For Physicians

Rotation overview

• Depending on the chosen track (general cancer imaging or PET-CT): 80% time will be spent reading cancer imaging studies with our CT, MR, U/S, or PET-CT.
• Approximately 20% of the Fellow's time can be dedicated to research, assuming that a detailed research project outline has been presented and approved by an attending radiologist as the project mentor. Research milestone schedules are clearly articulated and research progress is closely monitored.
• Four weeks of the CIP Fellowship is designated elective time. Elective time may be spent on approved research projects, or in other radiology disciplines elsewhere.
• On-call responsibilities consist of weekend day coverage.

Eligibility

U.S. applicants must be board eligible or board certified in radiology. Foreign applicants must be ECFMG certified, trained in radiology and eligible to obtain a clinical visa prior to starting the fellowship. The fellowship at Dana-Farber is structured in accordance with fellowship regulations as provided by the Department of Radiology at Brigham and Women's Hospital.

Teaching/conference responsibilities

There is a weekly seminar series designated for Category 1 CME credit, including introductory and modality-based lectures and disease-centric "blocks" thereafter. Other educational activities include a weekly radiology-pathology conference, drug conferences, and MRI/CT case conferences. These are in addition to continual one-on-one teaching throughout the day.

Fellowship supervision and evaluation

Dana-Farber Imaging Fellows will receive continuous on-site training, teaching, and feedback. Dr. Fiona Fennessy, Director of the Dana-Farber Cancer Imaging Fellowship Program, Dr. Atul Shinagare, Associate Director, Cancer Imaging Fellowship Program, and Dr. Annick D. Van den Abbeele, Chiaf of the Department of Imaging at Dana-Farber, will evaluate the fellow's performance.

Equipment and resources

State-of-the-art equipment includes 64-slice CT, 1.5-T and 3-T MRI, PET-CT, digital radiography, US and gamma camera systems. 

Application procedure

Applicants should send their C.V., personal statement, USMLE scores, and three reference letters (sent directly by the referees) to the address below. Canadian Physicians and Doctors of Osteopathy who are eligible may substitute documents: LMCC/MCCQE and COMLEX examinations.Other foreign applicants must send ECFMG certification.

Fiona M. Fennessy, MD, PhD, Cancer Imaging Fellowship Program Director
Atul Shinagare, MD, Cancer Imaging Fellowship Program Co-Director    
Dana-Farber Cancer Institute, Department of Imaging (DL101)
450 Brookline Avenue
Boston, MA 02215
Attention: Erin Foley

Phone: 617-632-4891
Fax: 617-582-8574
Email: CancerImagingFellowship@dfci.harvard.edu

Translational Cancer Imaging Clinical Fellowship

The Translational Cancer Imaging Fellowship is designed to teach trainees how imaging is being used in the context of the progress made in molecular medicine. Trainees will gain expertise in the understanding of the molecular mechanisms of cancer, the molecular-targeted drugs used to treat it, and the multiparametric anatomic and functional imaging tools available to diagnose cancer and evaluate responses to treatment.

Particular emphasis is placed on the use of imaging as a biomarker of response to treatment, the use and interpretation of tumor metrics, the comparative effectiveness of imaging procedures, the quantitation of imaging results, and the validation of imaging analysis methods.

Rotation overview

• Four months in nuclear medicine, including training in general nuclear medicine, cardiac imaging, and PET-CT with FDG, as well as novel PET tracers of cell proliferation, hypoxia, and apoptosis.
• Four months in cross-sectional imaging, including advanced applications with 64-slice CT, and 3T MRI.
• Four months in the design and implementation of a clinical trial that includes imaging as a primary endpoint. The trainee will learn to oversee all aspects of a clinical trial, which includes: concept development, protocol writing, protocol submission for institutional review board (IRB) approval, participant recruitment, informed consent, data collection, analysis, interpretation, and presentation of these data.

Eligibility

U.S. applicants must be board eligible or board certified in radiology. Foreign applicants must be ECFMG certified and eligible to obtain a clinical visa prior to starting the fellowship. The fellowship at Dana-Farber is structured in accordance with the fellowship regulations as provided by the Department of Radiology at Brigham and Women's Hospital (BWH) and the BWH GME office.

Application procedure

Applicants should send C.V., personal statement, USMLE scores,and three reference letters (which must be sent directly by the referees) to the address below. Canadian physicians and Doctors of Osteopathy who are eligible may substitute documents: LMCC/MCCQE and COMLEX examinations. Other foreign applicants must send ECFMG certification.

Dana-Farber Cancer Institute
Department of Imaging
Attn: Ashley Watterson, DL198
450 Brookline Avenue
Boston MA 02215

Phone: 617-632-4891
Fax: 617-582-8574
Email: CancerImagingFellowship@dfci.harvard.edu

Nuclear Oncology/PET-CT Clinical Fellowship

Dana-Farber Cancer Institute/Brigham and Women's Hospital, Cancer Imaging Program is accepting applications from MD/MD-PhD affiliates for a one-year Nuclear Oncology/PET-CT Fellowship with the opportunity to extend to a second year.

Dana-Farber Cancer Institute is a National Cancer Institute-designated comprehensive cancer center. The clinical fellowship will provide physicians with advanced clinical imaging training in oncology with a focus on PET-CT, novel therapies, and cross-sectional imaging. Fellows also have the opportunity to participate in various clinical research projects. Major areas of interest include molecular imaging, evaluation of novel therapeutic drugs, and new PET radiopharmaceuticals. 

Eligibility

Completion of the USMLE parts I, II, and III, and American Board of Radiology (ABR) and/or American Board of Nuclear Medicine (ABNM) eligible or certified.

Application procedure

Interested applicants should send a letter of intent, their C.V., and the names of three contacts for references, or three reference letters to:

Fiona M. Fennessy, MD, PhD, Cancer Imaging Fellowship Program Director
Atul Shinagare, MD, Cancer Imaging Fellowship Associate Director
Dana-Farber Cancer Institute, Department of Imaging (DL101)
450 Brookline Ave.
Boston, MA 02215
Attention: Ashley Watterson

Phone: 617-632-4891
Fax: 617-582-8574
Email: CancerImagingFellowship@dfci.harvard.edu

Women's Cancer Imaging Fellowship

This 12-month fellowship provides in-depth knowledge of the multidisciplinary diagnostic approach to medical oncology, with an emphasis on breast imaging and intervention. The Women's Cancer Imaging Fellow will spend 50% of his/her time in clinical rotations in breast imaging, rotating through both Dana-Farber and Brigham and Women's Hospital.

Thirty percent of his/her time will be spent in general (non-breast) imaging at Dana-Farber reading CT, MRI, US and PET-CT, and twenty percent of his/her time doing research (1 academic day/week starting in September).

Beginning with the 2018 academic year, Dana-Farber will be participating in the SBI Breast Imaging Fellowship Match.

The Breast Imaging Fellowship Match is sponsored by the Society of Breast Imaging and it will be managed by the National Resident Matching Program. In order to become a fellow with Dana-Farber Cancer Institute, you must register with the Radiology Match, of which Breast Imaging is a part.

To apply for a fellowship position, please send your resume to CancerImagingFellowship@dfci.harvard.edu. We will then contact you about arranging an interview.

Breast Imaging has implemented an All In Policy for the Match. This means that programs participating in the Match cannot extend any offers to candidates outside of the Match. Applicants can withdraw from the Match prior to the ranking deadline if they accept a position outside of the Match.

Dates of the Match

• Interview Period begins January 1, 2019
• March 21, 2019: Registration opens
• April 25, 2019: Ranking opens
• May 16, 2019: Quota change deadline
• June 13, 2017: Match Day
• July 1, 2018: Training begins

Cost of the Match

Applicants will pay a $75 registration fee to register for the Match.

Dana-Farber Cancer Institute

In the Breast Imaging section at Dana-Farber, the fellow will be exposed to cancer imaging in a high-risk breast cancer patient sub-group. The majority of patients have a history of breast cancer; however, both screening and high-risk screening populations are also imaged. There will be one attending to one trainee, at any one time. The fellow works closely with the breast care team of medical oncologists, radiation oncologists, and breast surgeons.

In addition, the high-quality breast imaging services of Dana-Farber are brought directly to the neighborhoods in which women live and work, by Boston's Mammography Van. This is the only mobile mammography program in the Commonwealth of Massachusetts. It provides screening mammograms and breast health education to women 40 years of age and older, regardless of their ability to pay. The van breaks down cultural, linguistic, financial, and logistical barriers to care and makes mammograms more accessible to those least likely to obtain one. The Women's Cancer Imaging Fellow will also help in interpreting these screening studies at Dana-Farber.

Brigham and Women's Hospital

The Breast Imaging Fellowship focuses on all aspects of breast imaging and interventional procedures. The Lee Bell Center for Breast Imaging at Brigham and Women's Hospital has a high volume clinical service, evaluating a wide variety of normal and pathologic processes with respective imaging studies. The breast imaging radiologists have a close working relationship with the surgeons and other staff at the Comprehensive Breast Center, which is located across the hall, encouraging frequent direct communication. The Women's Cancer Imaging Fellow will spend time in both screening and diagnostic mammography. Screening mammograms will be batch read and reviewed with attending staff.

Diagnostic imaging will include mammography (with tomosynthesis) and ultrasound, tailored to problem-solving on an individual case basis. The Lee Bell Center for Breast Imaging includes an on-site 3 Tesla magnet dedicated to breast imaging. It is supported by Computer Aided Detection and full biopsy capability. Breast MRI cases performed at Dana-Farber are also interpreted at the Lee Bell Center.

The Breast Imaging fellow will have structured time in the MRI suite, working directly with attending staff. He/she will also perform (under direct attending supervision) mammographically, sonographically and MRI-guided wire localizations, needle aspirations, and core needle biopsies. In addition to the rich clinical experience, Dana-Farber fellows while rotating at Brigham and Women's Hospital will be expected to participate in weekly multidisciplinary conferences, and radiology-pathology correlation conference.

Eligibility

U.S. applicants must be board eligible or board certified in radiology. Foreign applicants must be ECFMG certified and eligible to obtain a clinical visa prior to starting the fellowship. The fellowship at Dana-Farber is structured in accordance with the fellowship regulations as provided by the Department of Radiology at Brigham and Women's Hospital.

Teaching and conference responsibilities

There is a weekly seminar series designated for Category 1 CME credit, including introductory and modality-based lectures and disease-centric "blocks" thereafter. Other educational activities include a weekly radiology-pathology conference, drug conferences and MRI/CT case conferences. These are in addition to continual one-on-one teaching throughout the day.

Fellowship supervision and evaluation

Dana-Farber Cancer Imaging Fellows will receive continuous on-site training, teaching and feedback. Dr. Fiona Fennessy, Director of the Dana-Farber Cancer Imaging Fellowship Program, Dr. Atul Shinagare, Co-Director of the Fellowship Program, Dr. Sughra Raza, Director of Brigham and Women's Hospital Women's Imaging Fellowship, and Dr. Annick D. Van den Abbeele, Chief of the Department of Imaging at Dana-Farber, will evaluate the fellow's performance.

Equipment and Resources

State-of-the-art equipment includes 64-slice CT, 1.5-T and 3-T MRI, PET/CT, digital radiography, US and gamma camera systems.

Application procedure

Applicants should complete the application found on the Brigham and Women's Hospital website, where additional information about the Fellowship can be found. Be sure to specify on the application the program that you are applying for is the Dana-Farber Cancer Institute Breast Imaging Tract.

Fiona M. Fennessy, MD, PhD, Cancer Imaging Fellowship Program Director, Dana-Farber Cancer Institute
Atul Shinagare, MD, Cancer Imaging Fellowship Associate Director, Dana-Farber Cancer Institute
Sughra Raza, MD, Women's Imaging Fellowship Program Director, Brigham and Women's Hospital

Dana-Farber Cancer Institute
Department of Imaging (DL101)
450 Brookline Ave.
Boston, MA 02115
Attn: Ashley Watterson

Phone: 617-632-4891
Fax: 617-582-8574
Email: CancerImagingFellowship@dfci.harvard.edu